Intervention

Pitavastatin

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13

Recruiting0

Common conditions15

Lead sponsors shown12

Clinical trials

13 shown

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult ParticipantsNCT06982131 · 2025-06-04

ACTIVE_NOT_RECRUITING

Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast CancerNCT04705909 · 2021-01-15

Dyslipidemia of Obesity Intervention in TeensNCT02956590 · 2018-05-01

Safety and Efficacy of Statins for Chinese Patients With DyslipidemiaNCT03418974 · 2017-11-01

PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)NCT03070223 · 2017-03-14

Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsNCT02344290 · 2015-03-26

Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive PatientsNCT02144922 · 2014-05-01

Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or EfavirenzNCT01695954 · 2012-05-01

A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected SubjectsNCT01301066 · 2010-12-01

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With HypercholesterolemiaNCT00889226 · 2008-04-01

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's DiseaseNCT00548145 · 2007-11-01

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaNCT00344370 · 2006-08-01

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined DyslipidemiaNCT00309751 · 2005-12-01

Common conditions

Dyslipidemia4 HIV2 Obesity2 Type II Diabetes Mellitus2 Alzheimer Disease1 Breast Cancer1 Cardiovascular Diseases1 Cardiovascular Risk1 Dyslipidemias1 HIV-1 Infection1 Hypercholesterolemia1 Hypercholesterolemia With Type2DM1 Hyperlipidemia1 Hypertension1 Overweight1

Leading sponsors

Kowa Research Europe 2 Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1 Asan Medical Center 1 Carelon Research 1 Fudan University 1 Hoffmann-La Roche 1 JW Pharmaceutical 1 Kowa Research Institute, Inc. 1 Mansoura University 1 National Institute of Allergy and Infectious Diseases (NIAID) 1 NYU Langone Health 1 Osaka University 1

Trial status mix

COMPLETED9

UNKNOWN2

ACTIVE_NOT_RECRUITING1

TERMINATED1

Phase mix

PHASE36

PHASE44

PHASE12

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.